Literature DB >> 19796543

Health-related quality of life of school-age children with familial Mediterranean fever.

B Makay1, E Unsal, N Arslan, J W Varni.   

Abstract

OBJECTIVES: To describe and compare the parent proxy-reported and child self-reported physical and psychosocial HRQOL of school age children who have FMF with healthy peers.
METHODS: The Pediatric Quality of Life Inventory 4.0 (Peds QL 4.0) Generic Core Scales was used to measure HR-QOL. Fifty-one patients and 81 healthy peers were enrolled in the study. Patients were grouped according to their ages as : 1) Children (8-12 years) and 2) Adolescents (13-18 years). An accompanying parent completed the parent proxy-report of the Peds QL 4.0.
RESULTS: Peds QL scores of children (8-12 years) with FMF were significantly lower than healthy peers for physical and psychosocial functioning for both child self-report and parent proxy-report. The parent proxy-report and child self-reported Peds QL scores of adolescent patients (13-18 years) with FMF were lower than the healthy group for physical, emotional and school functioning; however no significant difference was detected regarding the social functioning. Adolescents with FMF had significantly higher social scores when compared to the younger age group (8-12 years) with FMF, 92.6 +/- 8.5 and 82.2 +/- 17.6, respectively (p=0.028). The scores of physical, emotional and school functioning were similar in both groups (p=0.73, p=0.93, and p=0.028). Correlations among child self-report subscales and proxy-report subscales were all significant and varied from moderate to high.
CONCLUSION: This study suggested that assessment of HRQOL has potential clinical implications for the healthcare needs of children and adolescents with FMF. Given the degree of reported impairment in their health-related quality of life, individualized counseling and interventions are needed.

Entities:  

Mesh:

Year:  2009        PMID: 19796543

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

Review 1.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

Review 2.  [Evidence-based treatment recommendations for familial Mediterranean fever : A joint statement by the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Kallinich; N Blank; T Braun; E Feist; U Kiltz; U Neudorf; P T Oommen; C Weseloh; H Wittkowski; J Braun
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

3.  Depression and anxiety in children and adolescents with familial Mediterranean fever.

Authors:  Balahan Makay; Neslihan Emiroğlu; Erbil Unsal
Journal:  Clin Rheumatol       Date:  2009-12-22       Impact factor: 2.980

4.  The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever.

Authors:  Philip J Hashkes; Steven J Spalding; Rula Hajj-Ali; Edward H Giannini; Anne Johnson; Karyl S Barron; Michael H Weisman; Noune Pashinian; Andreas O Reiff; Jonathan Samuels; Dowain Wright; Daniel J Lovell; Bin Huang
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

5.  Health-related quality of life in children with PFAPA syndrome.

Authors:  Claire Grimwood; Isabelle Kone-Paut; Maryam Piram; Linda Rossi-Semerano; Véronique Hentgen
Journal:  Orphanet J Rare Dis       Date:  2018-08-09       Impact factor: 4.123

Review 6.  Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.

Authors:  Caroline Vinit; Sophie Georgin-Lavialle; Aikaterini Theodoropoulou; Catherine Barbier; Alexandre Belot; Manel Mejbri; Pascal Pillet; Jana Pachlopnik; Sylvaine Poignant; Charlotte Rebelle; Andreas Woerner; Isabelle Koné-Paut; Véronique Hentgen
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

7.  Evaluation of quality of life and its associations with clinical parameters in pediatric patients with familial Mediterranean fever.

Authors:  Deniz Gezgin Yildirim; Sevcan Azime Bakkaloglu; A Sebnem Soysal Acar; Bulent Celik; Necla Buyan
Journal:  North Clin Istanb       Date:  2021-04-26

8.  [Results of the systematic literature search as basis for the "Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine" of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology].

Authors:  T Sahr; U Kiltz; C Weseloh; T Kallinich; J Braun
Journal:  Z Rheumatol       Date:  2020-09-30       Impact factor: 1.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.